Slideshow

Curcumin: New Use for an Old Spice?

Author(s):

James Phelps, MD

Although recent reviews caution against overenthusiasm, what if a simple, inexpensive, and extremely low-risk anti-inflammatory was at hand?

View the information in PDF format.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
lithium
McIntyre
John Krystal
emergency
peshkova Adobestock
Related Content
depression anxiety
July 17th 2025

First Patient Dosed in Phase 2b Study of GlyphAllo for Patients With Major Depressive Disorder, With or Without Anxious Stress

Leah Kuntz
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
spyrakot/Adobe Stock
July 14th 2025

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

Jessica Walters
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
Parkinson dopamine
July 10th 2025

Fava Beans, Dopamine, Depression, and Parkinson Disease

Sharon Packer, MD
GLP 1
July 7th 2025

Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

Roger S. McIntyre, MD, FRCPC
© 2025 MJH Life Sciences

All rights reserved.